FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
423 letters match. Newest first.
-
DrugsNewman Clinic, PLLC dba Newman Clinic
FDA told Newman Clinic its website misbranded compounded semaglutide and tirzepatide with false and misleading claims.
Medium -
DrugsNewSelf Limited dba NewSelf
FDA warns NewSelf over misleading website claims for compounded semaglutide and tirzepatide, including false compounder and FDA-approval implications.
Low -
Drugs24HrDoc, Inc. dba 24HrDoc
FDA says 24HrDoc's website misbrands compounded semaglutide and tirzepatide with false claims that it compounds them and that they match Ozempic, Wegovy, Mounjaro, Zepbound.
Medium -
DrugsDripgym Mobile Parent, LLC dba Amp Health
FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.
Low -
DrugsBluefitMD
FDA warned BluefitMD that its website falsely labels compounded semaglutide and tirzepatide as its own and as FDA-approved.
Low -
DrugsDeluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics
FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.
Low -
DrugsAspen Aesthetics dba Fifty 410
FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.
Low -
DrugsGenesis Health International Inc. dba Genesis
FDA warns Genesis over misleading website claims for compounded semaglutide and tirzepatide.
Low -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
DrugsDynamic Health Group dba SARMS AMERICA
FDA told SARMS AMERICA its SARMs products (Ostarine, MK-677, Cardarine, LGD-4033) are unapproved new drugs sold online without FDA approval.
High risk -
BiologicsMicrovascular Tissue, Inc.
FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.
High risk -
BiologicsCelularity, Inc
FDA warns Celularity that Interfyl is an unapproved new drug and unlicensed biological product marketed for orthopedic and wound uses.
High risk -
Drugs123Herbals
FDA warned 123Herbals that SILINTAN and other herbal products are unapproved drugs, and SILINTAN contains hidden meloxicam.
High risk -
DrugsIBSPOT.com Inc.
FDA says IBSPOT.com sold unapproved motion sickness patches containing diphenhydramine and diclofenac that the labels never listed.
High risk -
DrugsMaypharm
Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.
High risk -
DrugsEstaderma
FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.
High risk -
DrugsAceCosm
AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsDermax Co., Ltd
FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.
High risk -
DrugsMeamo
Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
Drugswww.usmedschoice.com
FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.
High risk -
DevicesLifeVac, LLC
FDA warns LifeVac it is selling its Rescue Suction Device without required FDA approval.
High risk -
BiologicsNew Life Medical Services, LLC
FDA says New Life Medical Services sells unapproved umbilical-cord, amniotic-fluid, and exosome products as drugs.
High risk -
DrugsPersōn & Covey, Inc.
FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.
High risk -
DrugsStellalife, Inc.
FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.
High risk -
DrugsGLP-1 Solution
GLP-1 Solution sells unapproved compounded retatrutide online and misleadingly compares semaglutide and tirzepatide to FDA-approved brand drugs.
High risk -
DrugsCanada Med Stop
Canada Med Stop marketed compounded semaglutide online as FDA-approved and generic, making the drugs misbranded.
Medium -
FoodMericon Industries, Inc.
Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.
High risk -
DrugsMel Honey US
FDA warned Mel Honey US that its Jimerito (Melipona) Honey eye drops are an unapproved new drug.
High risk -
DrugsTrew Balance
FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.
High risk -
DrugsAlzClipp / UniUni
FDA warns AlzClipp/UniUni that its AlzClipp nasal product is an unapproved new drug and misbranded with false FDA approval claims.
High risk -
AnimalMeds For Vets, LLC
Meds For Vets compounded unapproved animal drugs from bulk substances and failed manufacturing quality rules, including sterility controls.
High risk -
AnimalBoothwyn Pharmacy LLC
FDA warns Boothwyn Pharmacy over unapproved compounded animal drugs and falsified endotoxin records.
High risk -
DrugsConfer With
FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.
High risk -
FoodIndulgeRx Brands, Inc
FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.
Medium -
DrugsRevitalize Energy, Inc.
FDA warned Revitalize Energy that its Revitalize Energizing Eye Drops are an unapproved new drug and misbranded.
High risk -
FoodRoyal Diamond Imports, Inc.
FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.
High risk -
FoodHydroxie, LLC
FDA warned Hydroxie, LLC that its 7-OH tablets, strips, shots, and drink mix are unapproved drugs and an unsafe food additive.
High risk -
DrugsNefeteri Wellness
FDA says Nefeteri Wellness sells two unapproved colloidal silver vaginal gels promoted to treat infections.
High risk -
Drugswww.buycodeine.us
FDA warned website buycodeine.us for selling unapproved, misbranded opioid and stimulant drugs online without prescriptions.
High risk -
DrugsBio Wellness 444 LLC
Bio Wellness 444 sold Silver Bullet and Silver D douches as unapproved new drugs for vaginal infections.
High risk -
DevicesDRG Instruments GmbH
FDA warns DRG Instruments over unapproved salivary cortisol ELISA devices and quality system and reporting violations.
High risk -
DevicesUnited Health Products, Inc.
FDA warns United Health Products over unapproved significant-risk study of CelluSTAT absorbable hemostat and trial oversight failures.
High risk -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
AnimalHouse of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog
FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.
High risk -
AnimalHolista LLC dba HolistaPet
FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.
High risk -
DevicesExer Labs, Inc.
Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.
High risk -
DrugsAdvanced Pharmaceutical Technology
FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.
High risk -
DevicesRed Oak Instruments, LLC
Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.
High risk -
DrugsFiller Lux dba Filler Lux USA
FDA warned Filler Lux USA that it sells unapproved injectable lipolytic drugs online without FDA approval.
High risk -
DrugsJulian Naya Beauty LLC
FDA warned Julian Naya Beauty LLC that it sells six unapproved injectable fat-dissolving drugs on its website and social media.
High risk